Across TCGA pan-cancer cohorts, SLC25A6P6 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of SLC25A6P6’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where SLC25A6P6 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SLC25A6P6 is over-expressed in tumor.

UCEC are the cancer types where SLC25A6P6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC25A6P6 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	+0.030	.041	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: SLC25A6P6 RNA expression & survival · all SLC25A6P6 data types